About This Propofol Infusion Rate Calculator
This Propofol Infusion Rate Calculator is a vital tool for critical care clinicians to ensure the safe and accurate administration of propofol for ICU sedation. It allows for quick conversion from a weight-based dose (mcg/kg/min) to an infusion pump rate (mL/hr) for both 1% and 2% propofol concentrations. By automating this calculation, this Propofol Infusion Rate Calculator helps reduce the risk of medication errors in a high-stakes environment. Propofol remains one of the most widely used ICU sedatives, although the 2025 SCCM PADIS focused update now suggests dexmedetomidine over propofol when light sedation or a reduction in delirium are the highest priorities.
The Formula Explained
The calculation directly converts the weight-based dose to a volumetric rate using the fixed concentration of the propofol emulsion.
$$ \text{Rate (mL/hr)} = \frac{\text{Dose (mcg/kg/min)} \times \text{Weight (kg)} \times 60 \text{ min/hr}}{\text{Concentration (mg/mL)} \times 1000 \text{ mcg/mg}} $$
Clinical Interpretation & Limitations
The results from this Propofol Infusion Rate Calculator provide a reference for standard dosing, which must always be titrated to clinical effect.
- Dosing Range: For ICU sedation in adults, infusions are typically initiated at 5 mcg/kg/min and titrated upwards to achieve the desired level of sedation (e.g., a target RASS score). The usual maintenance range is 5 to 50 mcg/kg/min.
- Hemodynamic Effects: Propofol causes arterial and venous dilation, leading to a drop in blood pressure, which can be significant in hypovolemic, septic, or cardiac-compromised patients.
- PRIS Risk: The risk of Propofol-Related Infusion Syndrome rises with prolonged, high-dose infusion. The FDA label cites infusions >5 mg/kg/hr (~83 mcg/kg/min) for longer than 48 hours as the major dose-related risk factor, while 4 mg/kg/hr (~67 mcg/kg/min) is the general labeled dosing ceiling; PRIS can rarely occur at lower doses or shorter durations. Doses exceeding the usual maintenance range of 50 mcg/kg/min warrant reassessment and consideration of an alternative agent.
- Sedative Selection: The 2025 SCCM PADIS focused update suggests dexmedetomidine over propofol for sedation in mechanically ventilated adults where light sedation and/or a reduction in delirium are of highest priorities (conditional recommendation, moderate certainty of evidence).
Limitations
This calculator is intended for educational purposes and as a clinical aid; it is not a substitute for professional judgment. Always confirm calculations and adhere to institutional protocols. The user must account for the full clinical picture of the patient when making any dosing decision.
Frequently Asked Questions (FAQ)
1. Why does propofol cause hypotension?
Propofol induces vasodilation (widening of blood vessels) and has a negative inotropic effect (reduces heart muscle contractility), both of which contribute to a decrease in blood pressure. This effect is more pronounced during induction and in patients with underlying cardiac conditions or hypovolemia.
2. What is Propofol-Related Infusion Syndrome (PRIS)?
PRIS is a rare, but often fatal, metabolic complication of prolonged, high-dose propofol infusion. The FDA label identifies infusions >5 mg/kg/hr (~83 mcg/kg/min) for >48 hours as the major dose-related risk factor, although the syndrome has rarely been reported at lower doses or shorter durations. It is characterized by severe metabolic acidosis, rhabdomyolysis, hyperkalemia, renal failure, and cardiac failure.
3. Do I need to account for the calories in propofol?
Yes, for patients on prolonged infusions receiving nutritional support. Propofol 1% is a 10% lipid emulsion, providing 1.1 kcal per mL. This caloric load should be included in the daily nutritional assessment to avoid overfeeding.
4. Why is propofol preferred for neurological patients?
Its rapid offset (fast wake-up time) allows clinicians to pause the infusion and perform reliable neurological examinations, which is crucial for monitoring patients with brain injuries or those recovering from neurosurgery.
5. Can propofol be diluted?
No. Propofol is a lipid emulsion and should not be mixed with other diluents or drugs, as this can break the emulsion, leading to the formation of oil droplets and increasing the risk of pulmonary embolism. This is a key safety point for any Propofol Infusion Rate Calculator user.
6. When is dexmedetomidine preferred over propofol for ICU sedation?
The 2025 SCCM PADIS focused update suggests using dexmedetomidine over propofol for sedation in mechanically ventilated adults when light sedation or a reduction in delirium are the highest priorities (conditional recommendation, moderate certainty of evidence). Propofol remains a preferred agent when deep sedation, a rapid offset for neurologic assessment, or seizure control is required. The choice should be individualized to the patient’s hemodynamic status, sedation goal, and comorbidities.
📖 Sources:
- Lewis, K., Balas, M. C., Stollings, J. L., et al. (2025). A Focused Update to the Clinical Practice Guidelines for the Prevention and Management of Pain, Anxiety, Agitation/Sedation, Delirium, Immobility, and Sleep Disruption in Adult Patients in the ICU. Critical Care Medicine, 53(3), e711–e727.
- Devlin, J. W., et al. (2018). Clinical Practice Guidelines for the Prevention and Management of Pain, Agitation/Sedation, Delirium, Immobility, and Sleep Disruption in Adult Patients in the ICU. Critical Care Medicine, 46(9), e825–e873.
- DIPRIVAN® (propofol) Injectable Emulsion, USP [Prescribing Information]. Fresenius Kabi USA, LLC, Lake Zurich, IL. Accessed via DailyMed, U.S. National Library of Medicine.
- Marik, P. E. (2004). Propofol: therapeutic indications and side-effects. Current Pharmaceutical Design, 10(29), 3639–3649.
⚠️ Disclaimer:
This tool is for informational and educational purposes only and is not a substitute for professional clinical judgment. All treatment decisions must be made by a qualified healthcare professional considering the individual patient’s full clinical context.
